MRLA

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 7/18/2017
Contact Info
  • 7 Imber Street
  • Petach Tivka 4951141
  • Israel

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000797542
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 6770 - Blank Checks
Incorporated In: DE, USA
Year of Inc. 1995
Employees 10 a/o Mar 31, 2016
Company Officers/Contacts
Gadi Levin CFO
Thomas J. Craft, Jr. Securities Counsel
Company Directors
Alimi Ahmed Chairman
Yair Fudim
Estery Giloz-Ran
Dr. Asher Shmulewitz
Company Notes
  • Formerly=Zaxis International, Inc. until 10-2015
  • Note=11-02 the Company filed a petition for Bankruptcy in the U.S. Bankruptcy Court for the Northern District of Ohio. In October 2004, the Company emerged out of Bankruptcy free and clear of all liens, claims and encumbrances. The Company's new business plan is to seek new business opportunities.
  • Formerly=InFerGene Company (THE) until 8-95
Service Providers
Accounting/Auditing Firm
Deloitte Brightman Almagor Zohar
1 Azrieli Center
Tel Aviv, 67021
Israel

Legal Counsel
Thomas J. Craft, Jr. Esq.
18096 SE Heritage Dr
Ste. 2102
Tequesta, FL, 33469
United States

Investor Relations Firm
Not Available
MRLA Security Details
Share Structure
Market Value1 $428,341 a/o Sep 21, 2017
Authorized Shares 490,000,000 a/o Aug 29, 2017
Outstanding Shares 22,544,260 a/o Aug 29, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 3,369,013 a/o Jun 30, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Transfer Online, Inc.
Shareholders
Shareholders of Record 2,540 a/o Dec 31, 2016
Short Selling Data
Short Interest 478 (291.8%)
May 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security